Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7650
+0.0680 (9.76%)
At close: Sep 1, 2026, 4:00 PM EDT
0.8100
+0.0450 (5.88%)
After-hours: Sep 1, 2026, 7:52 PM EDT
Barinthus Biotherapeutics Employees
Barinthus Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 91 or -86.67% compared to the previous year.
Employees
14
Change (1Y)
-91
Growth (1Y)
-86.67%
Revenue / Employee
n/a
Profits / Employee
-$2,983,357
Market Cap
31.25M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | -91 | -86.67% |
| Dec 31, 2024 | 105 | -25 | -19.23% |
| Dec 31, 2023 | 130 | 23 | 21.50% |
| Dec 31, 2022 | 107 | 35 | 48.61% |
| Dec 31, 2021 | 72 | 24 | 50.00% |
| Mar 31, 2021 | 49 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Kyntra Bio | 34 |
| Lantern Pharma | 16 |
| NanoViricides | 7 |
| Polyrizon | 4 |
BRNS News
- 8 days ago - Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics - GlobeNewsWire
- 26 days ago - Barinthus Biotherapeutics price target lowered to $6 from $7 at Alliance Global - TheFly
- 26 days ago - Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire
- 26 days ago - Barinthus Biotherapeutics Quarterly report: Q2 2026 - Filings
- 26 days ago - Barinthus Biotherapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Barinthus Biotherapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire